ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer

  • Shinsuke Suzuki
  • Takashi AkiyoshiEmail author
ASO Author Reflections



The authors have no conflict of interest to disclose.


  1. 1.
    Shinko D, Diakos CI, Clarke SJ, Charles KA. Cancer-related systemic inflammation: the challenges and therapeutic opportunities for personalized medicine. Clin Pharmacol Ther. 2017;102:599–610.CrossRefGoogle Scholar
  2. 2.
    Rossi S, Basso M, Strippoli A, et al. Are markers of systemic inflammation good prognostic indicators in colorectal cancer? Clin Colorectal Cancer. 2017;16:264–74.CrossRefGoogle Scholar
  3. 3.
    Suzuki S, Akiyoshi T, Oba K, et al. Comprehensive comparative analysis of the prognostic value of systemic inflammatory biomarkers for patients with stage II/III colon cancer. Ann Surg Oncol. 2019.
  4. 4.
    Pagès F, Mlecnik B, Marliot F, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128–39.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Gastroenterological Surgery, Cancer Institute HospitalJapanese Foundation for Cancer ResearchTokyoJapan

Personalised recommendations